Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 2 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Asia, pharmacogenomics, and FDA's position on biomarkers.
You may also be interested in...
Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 3 of 3)
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Wall Street’s pipeline expectations, reducing R&D risk, and the California stem cell initiative.
Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 3 of 3)
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Wall Street’s pipeline expectations, reducing R&D risk, and the California stem cell initiative.
Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 1 of 3)
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with “The Pink Sheet” DAILY to discuss pharma/biotech deal flow and secrets to the Bay Area’s biotech success.